ARS Pharmaceuticals
SPRY
SPRY
76 hedge funds and large institutions have $864M invested in ARS Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
28% less capital invested
Capital invested by funds: $1.21B → $864M (-$341M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
76
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$11.7M | |
| 2 | +$8.46M | |
| 3 | +$6.07M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$5.28M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$4.3M |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$8.06M | |
| 3 | -$5.45M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.25M |
| 5 |
VA
VR Adviser
New York
|
-$3.71M |